Abstract PS10-09: Real-world analysis of concomitant medication use with potential drug-drug interactions (DDI) in patients with metastatic breast cancer (MBC) treated with cylin dependent kinase (CDK) 4/6 inhibitors
Year: 2021
Type: conference-abstract
Source: Cancer Research
Authors: Hope S. Rugo, Sanjeev Balu, Yunfeng Li, Guifang Chen, Xin Li, Stuart Turner, Roxana Sin
Institution: UCSF Helen Diller Family Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3133452276